What is the standard treatment for relapsed low-grade intestinal follicular lymphoma after previous DLBCL transformation?
When follicular lymphoma relapses after transforming to DLBCL, treatment options depend on several factors including your age, symptoms, which parts of your body are affected, how much the lymphoma has Show Full Answer
What is the standard treatment for relapsed low-grade intestinal follicular lymphoma after previous DLBCL transformation?
When follicular lymphoma relapses after transforming to DLBCL, treatment options depend on several factors including your age, symptoms, which parts of your body are affected, how much the lymphoma has grown, and your overall health.
For relapsed follicular lymphoma, common treatment approaches include:
* Targeted therapy drugs like lenalidomide (Revlimid), obinutuzumab (Gazyva), epcoritamab (Epkinly), or tazemetostat (Tazverik)
* Immunotherapy including monoclonal antibodies such as rituximab (Rituxan) and obinutuzumab (Gazyva), which can be used alone or with chemotherapy
* T-cell therapy such as epcoritamab-bysp (Epkinly), which helps T cells target and kill lymphoma cells
* Chemotherapy regimens combined with prednisone to reduce excessive B cells
* Bone marrow transplant may be considered, especially for younger patients, to replace damaged cells with healthy ones
For more aggressive situations, tafasitamab-cxix (Monjuvi) combined with lenalidomide and rituximab might be recommended.
Your oncologist will recommend second-line treatments based on what you've previously received and your current health status. Clinical trials may also provide access to newer treatment options still under development.
November 26, 2025